AnalystsShaunak DeepakShaunak Deepak's Stock Forecasts
AnalystsShaunak Deepak
Sectors:
Industries:
Analyst Ranking
Top 35%
#1682 out of 4872 analysts
Average Return
+46.4%
Win Rate
75%3 out of 4
Risk vs Reward
Poor
Good
Shaunak Deepak's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dicerna Pharmaceuticals IncDRNA | +157.73% | $2.91 | $7.50 | 2016-12-12 - 2017-12-12 | Buy |
Cytomx Therapeutics IncCTMX | +66.04% | $18.11 | $30.07 | 2017-03-27 - 2018-03-27 | Buy |
Dicerna Pharmaceuticals IncDRNA | +0.41% | $14.53 | $14.59 | 2018-08-15 - 2019-08-15 | Buy |
Shaunak Deepak Analyst Color
Get additional color on Shaunak Deepak's coverage of popular stocks
Shaunak Deepak's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dicerna Pharmaceuticals IncDRNA | 3 | Buy | N/A | N/A | Upgrades | 7 years ago |
Calithera Biosciences IncCALA | 1 | Buy | $280.00 | N/A | Maintains | 8 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $24.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.